Welcome Guest User|Palmetto GBA Medicare
Event Registration Portal
JJ: Open Draft Local Coverage Determination (LCD) Meeting
03/29/2018 JJ Part A
JJ Part B
10:00 AM - 12:00 PM Open Draft LCD Meeting
One Century Place Conference Center
26 Century Blvd, Room 104
Nashville, TN 37214

Palmetto GBA JJ A/B Medicare Administrative Contractor (MAC) has scheduled an Open Draft Local Coverage Determination (LCD) Meeting in order to allow for the submission of information related to the proposed LCDs. The general public is invited to submit information for Palmetto GBA's consideration.

 

Individuals who seek to attend the meeting in person MUST register to attend the event. Space is limited so registration is imperative. If you do not register to attend, you will be turned away if space is at capacity. You may register by logging in to the Event Registration Portal and selecting the event you wish to attend. New users must create a profile before registering for the event. To create a user profile, select the ‘Create Profile' link under the Login button on the blue menu bar and follow the instructions. You will receive your profile login information via e-mail once you complete registration. Please do not register to attend the meeting via the Event Registration Portal if you will be attending via conference call.

 

Individuals who seek to present information at the meeting MUST register to attend the event following the instructions above and must email a copy of their presentation to B.Policy@PalmettoGBA.com on or before March 21, 2018. Palmetto GBA asks that all presenters attend in person. Presenters will be selected on a first-come, first-serve basis and will be notified as to whether or not they have been selected, as well as the time they are allotted to present.

 

Presenters should bring the following:

  • A laptop or tablet that contains a VGA plug to connect to the projector. Presenters should have a 15 pin VGA female output.  If the computer has a different output please bring an adaptor ready to plug into a 15 pin male VGA. (required)
  • Copies of the presentation (optional)

If time and space are insufficient to accommodate all who request to present, Palmetto GBA will accept written comments and give them full and equal consideration.

 

If there are no requests to present information on the draft LCDs, the meeting may be canceled. Please check this page for updates on the meeting.

 

The following Draft LCDs are being presented for comment and will be viewable on the Medicare Coverage Database (MCD) on March 15, 2018. URLs will be provided here once the Draft LCDs post to the MCD. All comments should be submitted to the appropriate Proposed Contact located on each Draft LCD.
 
 

The A/B MAC LCDs out for comment are:

  1. Frequency of Hemodialysis DL34575
  2. Micro-Invasive Glaucoma Surgery (MIGS) DL37531

The MolDX LCDs out for comment are:

  1. GlycoMark Testing for Glycemic Control DL36761
  2. Helicobacter Pylori Infection Testing DL37592
  3. In Vitro Chemosensitivity & Chemoresistance Assays DL34554
  4. MolDX: Breast Cancer Indexâ„ 
  5. Genetic Assay DL35631
  6. MolDX: Circulating Tumor Cell Marker Assays DL35071
  7. MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Advanced Primary Peritoneal, Fallopian Tube and Ovarian Cancer DL37723
  8. MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Colorectal Cancer DL37719
  9. MolDX: Comprehensive Genomic Profiling to Guide Treatment in Patients with Metastatic Melanoma DL37721
  10. MolDX: ConfirmMDx Epigenetic Molecular Assay DL35632
  11. MolDX: Corus® CAD Assay DL37612
  12. MolDX: Cystatin C Measurement DL37581
  13. MolDX: Decipher® Prostate Cancer Classifier Assay DL35868
  14. MolDX: DecisionDx-Melanoma DL37725
  15. MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) DL37709
  16. MolDX: GeneSight® Assay for Refractory Depression DL35633
  17. MolDX: Genetic Testing for Lynch Syndrome DL35024
  18. MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) DL37699
  19. MolDX: MDS FISH DL37602
  20. MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels DL37713
  21. MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) DL37701
  22. MolDX: Pigmented Lesion Assay (PLA) DL37715
  23. MolDX: Prolaris™ Prostate Cancer Genomic Assay DL35869
  24. MolDX: ProMark Risk Score DL36665

*Pending CMS decision on NGS NCD

 

Conference Call Number: 1-877-375-2583
Participant Code: 987225

 

Tennessee (individual meetings will not be held in GA or AL)
Time: 10 a.m. to 12 p.m. CDT on March 29, 2018
Location: One Century Place Conference Center, 26 Century Blvd., Room 104, Nashville, TN 37214